This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Dec 12, 2001Pharis Biotec Grants Exclusive Patent License to Nichols Institute Diagnostics For Method of Detecting Active Parathyroid Hormone
German-based therapeutic developer Pharis Biotec GmbH, and Nichols Institute Diagnostics, a wholly-owned subsidiary of Quest Diagnostics Incorporated , announced today that Pharis Biotec has...
Dec 3, 2001
Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced today that it had completed the previously announced acquisition of...
Dec 3, 2001Quest Diagnostics Successfully Completes Contingent Convertible Debentures Offering, Totaling $250 Million
Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced the successful completion of its public offering of 1.75% Contingent...
Nov 30, 2001Drug Use in the General U.S. Workforce Increased in First Half of 2001 According to Quest Diagnostics' Drug Testing Index
Drug use in the general U.S. workforce increased in the first half of 2001, according to the semi-annual Drug Testing Index released today by Quest Diagnostics Incorporated , the leading provider...